Kidney Disease Affects All Socioeconomic Groups—Not Just the Wealthy

The myth that kidney disease is a “rich person’s ailment” is false and harmful. Chronic kidney disease (CKD) prevalence is higher in low‑income and marginalized populations due to:

• Diabetes & Hypertension: Leading causes; more prevalent and poorly controlled in underserved groups.
• Access Barriers: Lack of insurance, transportation, nephrology specialists, early screening.
• Environmental Exposures: Heavy metals, agrochemicals, heat stress (agricultural workers).
• Social Determinants: Food deserts (high‑sodium processed foods), chronic stress, limited health literacy.

Data

• US: CKD prevalence 16% overall; 23% in non‑Hispanic Black adults vs. 14% White (NHANES).
• Low income associated with 2× higher ESRD incidence.
• Globally: CKD disproportionately affects low‑/middle‑income countries.

Equity Actions

• Community‑based screening (e.g., kidney mobile units).
• Expand Medicaid/Medicare coverage for early CKD management.
• Address food insecurity, environmental justice.
• Diversify nephrology workforce; culturally competent care.

Kidney disease is a public health equity issue. Framing it as a “wealthy” problem diverts resources from those most affected.